| Drugs with this side effect as MedDRA Preferred Term
			
			
	  	5-ASA
				
				
					Bronchitis: postmarketing, 2% - 3% 5-aza-2'-deoxycytidine
				
			5-azacytidine
				
			A77 1726
				
			CAS 76095-16-4
				
			CAS 76420-72-9
				
			FAMP
				
			FTY720
				
				
					Bronchitis: common, 8% - 9.09% Glat copolymer
				
			Goserelin
				
			Humalog
				
				
					Bronchitis: 6.98% - 7.41% Insulin
				
			K779
				
			L-Dmp
				
			Lantus
				
				
					Bronchitis: 14.1% - 15.2% Leuprorelin
				
			Lisinopril
				
			Lovaza
				
			MDV3100
				
			Metrodin
				
			NTBC
				
			NovoLog
				
				
					BronchitisAcute bronchitisNuvaRing
				
			Octreotide
				
			PGE1
				
			Photofrin
				
				
					Bronchitis: 2.02% - 10.5% Photofrin II
				
			Triptorelin
				
			UDCA
				
			VACV
				
			abacavir
				
			abacavir-lamivudine
				
			acamprosate
				
			alfuzosin
				
			aliskiren
				
				
					Bronchitis: 0.948% - 3.1% almotriptan
				
			ambrisentan
				
				
					Bronchitis: 1.49% - 4.62% anagrelide
				
			anastrozole
				
			atorvastatin
				
			avanafil
				
			azelastine
				
			benazepril
				
			benazeprilat
				
			betaxolol
				
				
					Bronchitis: postmarketing bexarotene
				
			bezafibrate
				
			bicalutamide
				
			bimatoprost
				
			bisoprolol
				
			boceprevir
				
			bortezomib
				
			bosentan
				
				
					Bronchitis: 7% Acute bronchitis: 2% bosutinib
				
			brimonidine
				
			brinzolamide
				
			budesonide
				
				
					Bronchitis: postmarketing buprenorphine
				
			bupropion
				
				
					Bronchitis: rare, infrequent, 2% butorphanol
				
			cabergoline
				
			candesartan
				
			candesartan cilexetil
				
			capecitabine
				
			capsaicin
				
			carbamazepine
				
			carnitine
				
			carvedilol
				
			cefepime
				
			cefpodoxime
				
			cefuroxime
				
			celecoxib
				
			cerivastatin
				
			cetirizine
				
			cevimeline
				
			chlorhexidine
				
			ciclesonide
				
			cidofovir
				
			cilazapril
				
			cilostazol
				
			citalopram
				
				
					Bronchitis: infrequent, uncommon, frequent Acute bronchitis: infrequent clobazam
				
			clomipramine
				
			clonazepam
				
			clopidogrel
				
			clozapine
				
			conjugated estrogens
				
			copolymer 1
				
			dabigatran etexilate
				
			darifenacin
				
			deferasirox
				
			delavirdine
				
			deprenyl
				
			desloratadine
				
			diclofenac
				
			dihydroergotamine
				
			diltiazem
				
				
					Bronchitis: 0.633% - 4.08% donepezil
				
			dorzolamide
				
			doxazosin
				
			doxepin
				
			doxorubicin
				
			doxycycline
				
			doxycycline hyclate
				
			eletriptan
				
			eplerenone
				
			eprosartan
				
			estradiol
				
				
					Bronchitis: 3.45% - 7.87% etodolac
				
				
					Bronchitis: postmarketing etoricoxib
				
			everolimus
				
			exemestane
				
			famotidine
				
			febuxostat
				
			felodipine
				
			fenofibrate
				
			fenofibric acid
				
			fentanyl
				
			finasteride
				
			fludarabine
				
			flunisolide
				
			fluoxetine
				
			flurbiprofen
				
			fluticasone
				
			fluticasone furoate
				
				
					Bronchitis: 1.88% - 2.98% fluticasone propionate
				
			fluvastatin
				
			fluvoxamine
				
				
					Bronchitis: rare, infrequent, 2% formoterol
				
				
					Bronchitis: 4.6% Acute bronchitisfosphenytoin
				
			gabapentin
				
				
					Bronchitis: infrequent, 0.8% - 3.4% gadobenate dimeglumine
				
			galantamine
				
			gliclazide
				
			gold sodium thiomalate
				
			ibandronate
				
			ibuprofen
				
			imiquimod
				
			indapamide
				
			insulin detemir
				
			iodixanol
				
			ipratropium bromide
				
			isomannide
				
			isopropyl unoprostone
				
			isosorbide-5-mononitrate
				
			itraconazole
				
			lamivudine
				
			lamotrigine
				
			lanreotide
				
			lansoprazole
				
			lanthanum carbonate
				
			lasofoxifene
				
			latanoprost
				
			leflunomide
				
			lenalidomide
				
				
					Bronchitis: postmarketing, very common, 11.3% - 11.6% leuprorelin acetate
				
			levetiracetam
				
			levonorgestrel
				
			liraglutide
				
				
					Bronchitis: postmarketing losartan
				
			macitentan
				
			mannitol
				
			maraviroc
				
				
					Bronchitis: 5% - 7% Acute bronchitismedroxyprogesterone
				
			medroxyprogesterone acetate
				
			meloxicam
				
			memantine
				
			methylphenidate
				
			metipranolol
				
			metronidazole
				
				
					Bronchitis: 1.08% - 1.59% minocycline
				
			mirtazapine
				
			misoprostol
				
				
					Bronchitis: postmarketing modafinil
				
			mometasone
				
			mometasone furoate
				
			montelukast
				
			moxonidine
				
			mycophenolate mofetil
				
			mycophenolic acid
				
			naltrexone
				
			naproxen
				
			naratriptan
				
			nateglinide
				
			nedocromil sodium
				
			nefazodone
				
			niacin
				
			nicorandil
				
			nicotine
				
			nilotinib
				
			ofatumumab
				
			ofloxacin
				
			olmesartan
				
				
					Bronchitis: common, 0.404% - 5.05% Acute bronchitis: 0.431% - 2.02% olmesartan medoxomil
				
			olodaterol
				
			oseltamivir
				
				
					Bronchitis: postmarketing, 1.6% - 17% oxcarbazepine
				
			oxybutynin
				
			oxycodone
				
			paclitaxel
				
			paliperidone
				
			pantoprazole
				
			paroxetine
				
				
					Bronchitis: infrequent, uncommon, 1% - 2% pegaptanib
				
			pegaptanib sodium
				
			pemirolast
				
			pentamidine
				
			pentostatin
				
			pergolide
				
			perindopril
				
			perindopril erbumine
				
			phenytoin
				
			pilocarpine
				
			pimecrolimus
				
				
					Bronchitis: 0.375% - 10.7% Acute bronchitis: 0% - 1.5% pioglitazone
				
			pixantrone
				
			poly(styrene sulfonate
				
			pomalidomide
				
			pramipexole
				
			pregabalin
				
			progesterone
				
			propranolol
				
			pyridostigmine
				
			quetiapine
				
			rabeprazole
				
			raloxifene
				
			raltegravir
				
			ramipril
				
			rapamycin
				
			reboxetine
				
			remifentanil
				
			repaglinide
				
			rescinnamine
				
			ribavirin
				
			rifapentine
				
			riluzole
				
			risedronate
				
			risperidone
				
			ritonavir
				
			rivastigmine
				
			rofecoxib
				
			ropinirole
				
				
					Bronchitis: frequent, 3% Acute bronchitis: infrequent rosuvastatin
				
			rufinamide
				
			salbutamol
				
				
					Bronchitis: postmarketing, 0% - 5% salmeterol
				
				
					Bronchitis: 3% - 7% Acute bronchitissalmon calcitonin acetate
				
			samarium
				
			saquinavir
				
			sertraline
				
			sevelamer hydrochloride
				
				
					Bronchitis: 11.1% - 12.9% sibutramine
				
			sildenafil
				
			simvastatin
				
			sitagliptin
				
				
					BronchitisAcute bronchitissitaxsentan
				
			sodium
				
			sparfloxacin
				
			stavudine
				
			sumatriptan
				
			sunitinib
				
				
					Bronchitis: postmarketing tacrolimus
				
			tadalafil
				
			tamoxifen
				
			telmisartan
				
			temozolomide
				
			temsirolimus
				
			terazosin
				
			testosterone
				
			testosterone undecanoate
				
			tetrabenazine
				
			thalidomide
				
			tiagabine
				
			tipranavir
				
			tizanidine
				
			tobramycin
				
			tolcapone
				
			tolterodine
				
			topiramate
				
			tramadol
				
				
					Bronchitis: postmarketing, uncommon Acute bronchitistrandolapril
				
				
					Bronchitis: postmarketing, 0.3% - 3.9% trandolaprilat
				
				
					Bronchitis: postmarketing travoprost
				
			treprostinil
				
			triamcinolone
				
			triamcinolone acetonide
				
			unoprostone
				
			v 1784
				
				
					Bronchitis: postmarketing, 1% - 3% valdecoxib
				
			valganciclovir
				
			valproate
				
			valsartan
				
			vandetanib
				
			varenicline
				
			venlafaxine
				
			vigabatrin
				
			vinflunine
				
			zaleplon
				
			zanamivir
				
			zidovudine/lamivudine
				
			zolmitriptan
				
			zolpidem
				
			zopiclone
				
			 | Drugs with this indication |